Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Rep. Calls For Triclosan Ban, Approval Redo, Following FDA, EPA Response

This article was originally published in The Tan Sheet

Executive Summary

Rep. Ed Markey wants to ban many personal care applications of the antimicrobial triclosan and is crafting legislation to authorize government to remove potentially dangerous ingredients from the market more quickly

You may also be interested in...



FDA Should Ban Triclosan, House Democrats Urge

More Democratic House members are calling for a ban on triclosan use in personal-care products with a letter to FDA Commissioner Margaret Hamburg.

FDA Should Ban Triclosan, House Democrats Urge

More Democratic House members are calling for a ban on triclosan use in personal-care products with a letter to FDA Commissioner Margaret Hamburg.

FDA Should Ban Triclosan, House Democrats Urge

More Democratic House members are calling for a ban on triclosan use in personal-care products with a letter to FDA Commissioner Margaret Hamburg.

Related Content

Topics

UsernamePublicRestriction

Register

PS103999

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel